Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases.
暂无分享,去创建一个
V. Fischetti | M. Suárez-Fariñas | J. Krueger | J. Fuentes-Duculan | E. Guttman‐Yassky | Assaf Raz | A. Shemer | N. Dhingra | J. Gittler | E. Guttman-Yassky
[1] Z. Modrušan,et al. Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. , 2012, The Journal of allergy and clinical immunology.
[2] M. Suárez-Fariñas,et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.
[3] V. Fischetti,et al. Cellular aspects of the distinct M protein and SfbI anchoring pathways in Streptococcus pyogenes , 2012, Molecular microbiology.
[4] D. Jarrossay,et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β , 2012, Nature.
[5] J. Krueger,et al. Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts. , 2011, The Journal of allergy and clinical immunology.
[6] A. Bowcock,et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. , 2011, The Journal of allergy and clinical immunology.
[7] A. Oranje. Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score. , 2011, Current problems in dermatology.
[8] Chad W. Euler,et al. A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus Strains , 2010, Antimicrobial Agents and Chemotherapy.
[9] Chad W. Euler,et al. Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.
[10] Donald Y M Leung,et al. Recent insights into atopic dermatitis and implications for management of infectious complications. , 2010, The Journal of allergy and clinical immunology.
[11] J. Carucci,et al. Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.
[12] Lisa C. Zaba,et al. Th17 cytokines interleukin (IL)‐17 and IL‐22 modulate distinct inflammatory and keratinocyte‐response pathways , 2008, The British journal of dermatology.
[13] V. Fischetti,et al. Bacteriophage lysins as effective antibacterials. , 2008, Current opinion in microbiology.
[14] D. Leung. Chapter 3. The role of Staphylococcus aureus in atopic eczema , 2008 .
[15] J. Carucci,et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. , 2007, The Journal of allergy and clinical immunology.
[16] A. Finlay,et al. Staphylococcus aureus re‐colonization in atopic dermatitis: beyond the skin , 2005, Clinical and experimental dermatology.
[17] M. Cork. The role of Staphylococcus aureus in atopic eczema: treatment strategies , 1996 .